fgfr2, and shh were evaluated after RA treatment to disclose a putative molecular network underlying RA effect. In situ hybridization analysis showed that RA is able to alter cyp26a1, sox9, tgfβ2, and id2 spatial distribution; to increase rarβ, meis2, and hoxb5 expression levels; and has a very modest effect on sox2, fgf10, fgfr2, and shh expression levels. Overall, these findings support a role for RA in the proximal-distal patterning and branching morphogenesis of the avian lung and reveal intricate molecular interactions that ultimately orchestrate branching morphogenesis.
Introduction
The avian respiratory system is constituted by the parabronchial lung that is involved in gas exchange and air sacs which control air movements. In the chicken embryo, Gallus gallus, the embryonic lung originates from the primitive foregut around embryonic day 3 (E3) [1] . Subsequent airway branching leads to the formation of the primary bronchus (mesobronchus) and, by lateral sprouting, secondary bronchi emerge from the dorsal surface of the mesobronchus. This lateral (or monopodial) branching is similar to the domain branching observed during mammalian lung development [2] . In addition to these morphological resemblances, the molecular mechanisms underlying chick lung branching appear to be highly conserved. For instance, it has been shown that FGF (fibroblast growth factor) signaling is important for the events that control primary bud formation [3] . Moreover, it is also essential for pulmonary morphogenesis since in vitro FGF receptor Abstract Retinoic acid (RA) is of major importance during vertebrate embryonic development and its levels need to be strictly regulated otherwise congenital malformations will develop. Through the action of specific nuclear receptors, named RAR/RXR, RA regulates the expression of genes that eventually influence proliferation and tissue patterning. RA has been described as crucial for different stages of mammalian lung morphogenesis, and as part of a complex molecular network that contributes to precise organogenesis; nonetheless, nothing is known about its role in avian lung development. The current report characterizes, for the first time, the expression pattern of RA signaling members (stra6, raldh2, raldh3, cyp26a1, rarα, and rarβ) and potential RA downstream targets (sox2, sox9, meis1, meis2, tgfβ2, and id2) by in situ hybridization. In the attempt of unveiling the role of RA in chick lung branching, in vitro lung explants were performed. Supplementation studies revealed that RA stimulates lung branching in a dose-dependent manner. Moreover, the expression levels of cyp26a1, sox2, sox9, rarβ, meis2, hoxb5, tgfβ2, id2, fgf10, inhibition impairs lung branching [4] . Similarly, canonical WNT (wingless-related integration site) signaling is active in early stages of chick lung branching morphogenesis [5] , whereas non-canonical WNT signaling (via WNT-5a) has been implicated in pulmonary distal airway and vasculature development [6] . Likewise, SHH (sonic hedgehog) signaling members are expressed in chick embryonic lung [7] and their importance in chick lung branching was revealed in talpid 3 mutants that display abnormal (hypoplastic) lung phenotype due to a defective SHH signaling [8] . Other signaling pathways such as microRNAs [9] and TGFβ-BMP (transforming growth factor β-bone morphogenetic protein) signaling [10] have also been characterized in the chick developing lung. Overall these signaling pathways behave similarly to their mammalian counterparts (reviewed in [11] ). Nonetheless, there are many other molecular players, already identified in mammalian lung branching, that have not been described in the chick lung, as for instance retinoic acid signaling [12] among many others [13, 14] .
Retinoic acid (RA), the active metabolite of vitamin A, is vital for vertebrate embryonic development, namely in somitogenesis, neurogenesis, and organogenesis (reviewed in [15, 16] ). Nonetheless, abnormal levels of RA due to metabolic or signaling alterations elicit congenital malformations (reviewed in [17] ). Retinol, the dietary form of retinoic acid, enters the cell via transmembrane protein STRA6 (stimulated by retinoic acid 6) [18] . Once in the cytoplasm, retinol undergoes a series of intracellular oxidative reactions until it is transformed into retinal by retinol dehydrogenase; eventually, retinal is oxidized to RA by retinal dehydrogenase (RALDH1-3). RA intracellular levels must be sharply regulated at the tissue level which is achieved by the action of enzymes belonging to the cytochrome P450 26 subfamily (CYP26A1, B1, and C1) (reviewed in [19] ). These enzymes degrade RA and together with synthesizing enzymes ultimately regulate the availability of this molecule for signaling. RA is then transferred to the nucleus bound to the cellular retinoic acid-binding transporter where it binds to specific retinoic acid nuclear receptors (RARs). There are three subtypes (RARα, RARβ, and RARγ) that bind to retinoic X receptor (RXR) to form a heterodimer that recognizes specific DNA sequences called RARE (retinoic acid response element) in the promoter region of retinoid-target genes. In the presence of RA, conformational changes occur that facilitate transcription of specific genes that convey the appropriate cellular responses (reviewed in [20] ). Molecular targets of RA signaling pathway include transcription factors such as nuclear receptors (namely rarβ), homeodomain genes, genes coding for retinoic acid signaling members (for instance, cyp26a1), and genes belonging to other signaling pathways as for instance fgf10, shh or tgfβ [15] .
Lung development is a complex process deeply dependent on interactions between signaling pathways that promote both spatial and temporal synchronization of pulmonary morphogenesis. RA is fundamental for proper lung patterning, and pulmonary morphogenesis depends on the timely expression of RA signaling genes. In mammals, maternal vitamin A deficiency causes severe lung abnormalities [21, 22] that are replicated with the ablation of either RARs or RALHD, namely lung agenesis and lung hypoplasia [23] [24] [25] . It has been demonstrated that RA plays a crucial role in the events underlying primary lung formation; RA-deficient endoderm fails to develop the lung bud primordium due to the disruption of the RA downstream molecular network that involves FGF, SHH, WNT signaling, and hox genes [26] [27] [28] . During branching morphogenesis, RA signaling activity seems to be restricted to the proximal-most region of the lung which support's the establishment of proximal airways phenotype, most likely through rarβ receptor [29] . On its turn, downregulation of RA signaling in the distal lung enables the expression of specific genes that facilitate budding of the pulmonary tree [12] . In general, RA is involved in proximal-distal patterning of the developing lung. RA is also required for smooth muscle cell differentiation of the developing airways [30] and alveologenesis (reviewed in [31] ).
The importance of RA signaling in mammalian lung development is quite well explored; however, nothing is known about its function in the chick lung. Accordingly, to gain new insights into the role of retinoids in the chick developing lung, we examined the spatial distribution of key members of this signaling pathway, specifically stra6, raldh2, raldh3, cyp26a1, rarα, and rarβ. In situ hybridization revealed a common mesenchymal expression for all the studied signaling members. Furthermore, we analyzed the expression pattern of some putative RA downstream targets selected according to their association with mammalian lung, such is the case of sox2, sox9, tfgβ2, and id2, or chick limb development, namely meis1 and meis2. To determine RA function in early organogenesis of the avian lung, in vitro lung explants were supplemented with increasing doses of RA and its impact on lung branching and gene expression (cyp26a1, sox2, sox9, rarβ, meis2, hoxb5, tgfβ2, id2, fgf10, fgfr2, and shh) was evaluated. With this study, we demonstrated the importance of retinoic acid signaling in early stages of chick lung morphogenesis and unveil a retinoic acid-dependent molecular network that most likely contributes to appropriate lung branching and patterning.
Materials and methods

Ethical statement
This work, performed at early stages of chick development, does not need ethical approval from review board institution or ethical commission.
Eggs and embryos
Fertilized chicken eggs, Gallus gallus, were incubated between 4.5 and 5.5 days in a 49% humidified atmosphere at 37 °C. Embryonic lungs were dissected under a stereomicroscope (Olympus SZX16, Japan) and staged in b1, b2, and b3 according to the number of secondary buds formed: 1, 2 or 3, respectively [4] . Dissected lungs were processed for in situ hybridization or for in vitro lung explant culture.
In vitro lung explant culture
After dissection in PBS, stage b2 lungs were transferred to nucleopore polycarbonate membranes with 8 μm pore size (Whatman, USA) and incubated in 24-well culture plates. Membranes were presoaked in 400 μL of Medium 199 (Sigma, USA) for 1 h before the lungs were placed on them. Lungs were randomly assigned one of four experimental groups (n ≥ 15 per condition): 0.1, 1, 10 µM of retinoic acid (R2625, Sigma) or DMSO (1 µL/mL) as control (since retinoic acid was resuspended in this solvent). Chick lung explants were kept in culture for 48 h as previously described [4] . At the end of the culture, explants were washed in PBS, fixed in a 4% formaldehyde solution, and stored at 4 °C, overnight. Lastly, explants were processed for in situ hybridization.
Morphometric analysis
Lung branching was monitored daily by photographing the explants. At D0 (0 h) and D2 (48 h) of culture, the total number of peripheral airway buds was determined. For the morphometric analysis, the internal perimeter of the lung (epithelium) and the outer perimeter of the lung (mesenchyme) were assessed at D0 and D2 using AxionVision Rel. 4.3 (Carl Zeiss GmbH, Germany). The results of branching and morphometric analysis were expressed as D2/D0 ratio. All quantitative morphometric data are presented as mean ± SEM. Statistical analysis was performed using SigmaStat 3.5 (Systat Software Inc., USA). Since normality test failed in branching analysis, Kruskal-Wallis one-way analysis of variance was used followed by a Dunn's method for pairwise multiple comparisons. Regarding morphometric analysis, one-way ANOVA was used followed by a Holm-Sidak method for pairwise multiple comparisons.
RNA probes
Antisense digoxigenin-labeled RNA probes were produced as previously described: stra6 [32] , raldh2 [33] , raldh3 [34] , rarα and rarβ [35] , cyp26a1 [36] , meis1 and meis2 [37] , hoxb5 [38] , tgfβ2 [39] , l-cam and sox2 [40] , sox9 [41] , fgf10 [5] , fgfr2 [42] , shh [43] , and id2 [44] . Probes were obtained by in vitro transcription reaction using Dig RNA labeling mix (Roche Applied Sciences, Germany) according to the manufacturer's protocol.
Whole mount in situ hybridization
Dissected lungs were fixed in a 4% formaldehyde solution with 2 mM EGTA in PBS, pH 7.5, at 4 °C overnight. Afterward, lungs were dehydrated through a methanol series and stored at −20 °C. Whole mount in situ hybridization (n ≥ 9 per stage/gene for whole lungs and n ≥ 4 per gene/condition for lung explants) was performed as previously described [45] . Each group of lungs/probes was processed simultaneously and developed for the same amount of time. All the lungs were photographed with an Olympus U-LH100HG camera coupled to a stereomicroscope (Olympus SZX16).
Cross section preparation
Hybridized chicken lungs were dehydrated through an ethanol series, embedded in 2-hydroxyethyl methacrylate (Heraeus Kulzer, Germany) and sectioned in 25-μm-thick slides by a rotatory microtome (Leica RM 2155, Germany). All lung sections were photographed using a camera (Olympus DP70) coupled to a microscope (Olympus BX61). Afterwards, slide sections were stained with hematoxylin-eosin as previously described [9] and photographed again at the same magnification.
Results
Expression analysis of retinoic acid signaling pathway
To study the expression pattern of the retinoic acid signaling members and potential targets of the pathway, embryonic chick lungs were analyzed by in situ hybridization to characterize the expression pattern of stra6, raldh2, raldh3, cyp26a1, rarα, rarβ, sox2, sox9, meis1, meis2, and tfgβ2. Representative lungs of the three stages studied were then processed for histological sectioning. Additionally, to clearly identify the epithelial and mesenchymal compartment, and thus facilitate image analysis, slide sections were stained with hematoxylin-eosin (Figs. S1 and S2).
stra6 expression seems to be present in the most proximal region of the lung, namely in the trachea (Fig. 1a , dark arrowhead) and until the first secondary bud formed. On the other hand, it is absent from both distal epithelium and mesenchyme (Fig. 1c, dagger) , and also from secondary bronchi (Fig. 1b, asterisk) . This expression pattern 1 3 is constant for the three stages studied. Histological sectioning of hybridized lungs clearly showed that stra6 is expressed in the periepithelial mesenchyme surrounding the main bronchus (Fig. 1d , double dagger) and absent in the lung epithelium (Fig. 1d, asterisk and black arrow) .
raldh2 is expressed in the ventral mesenchyme (Fig. 1e , open arrowhead) and in the outermost region of the dorsal mesenchyme (Fig. 1f, dashed arrow) . On its turn, it is not expressed in the tracheal region (Fig. 1g, dark arrowhead) , in the epithelium of the main bronchus (Fig. 1f, black  arrow) , and in the distal-dorsal mesenchyme (Fig. 1g, dagger) . This pattern is consistent in the three stages studied. Histological sections confirmed that raldh2 transcript is exclusively located in the cells that outline the embryonic lung, the mesothelium (Fig. 1h, section sign) , and in the ventral mesenchyme. Furthermore, it is not present in the secondary buds (Fig. 1h, asterisk) . Additionally, raldh3 expression pattern was also assessed but it was not detected in the embryonic chick lung in the three stages studied (data not shown).
cyp26a1 is present in the mesenchyme of the trachea region (Fig. 1i, dark arrowhead) , in the dorsal mesenchyme adjacent to the uppermost secondary bud (Fig. 1k,  dashed arrow) , and in the ventral mesenchyme (Fig. 1k,  open arrowhead) . The distal region of the embryonic lung, mesenchyme, and epithelium, does not express cyp26a1 (Fig. 1j, dagger) . There are no differences between the three stages studied. Slide sectioning confirmed that expression is not present in the entire epithelium, namely main bronchi and secondary bronchi (Fig. 1l, asterisk) .
rarα is ubiquitously expressed throughout all pulmonary mesenchyme of the chick lung, in the three stages studied (Fig. 1m-o) . Histological sections revealed that this gene is absent from the epithelial compartment of the main bronchi and secondary bronchi (Fig. 1p, asterisk) .
rarβ expression is evident in the mesenchyme of the tracheal region (Fig. 1r, dark arrowhead) and also in the dorsal (Fig. 1r , dashed arrow) and ventral mesenchyme (Fig. 1s,  open arrowhead) . Moreover, it is absent from the distal region of the main bronchi (Fig. 1s, dagger) . rarβ expression seems to be stage dependent since it is not detected in stage b1 lungs (Fig. 1q) but it is highly expressed in stages b2 and b3 ( Fig. 1r and s, respectively) . Sectioning of the hybridized lungs clearly showed that rarβ is not expressed in the epithelium of secondary buds (Fig. 1t , asterisk) but in the surrounding (dorsal) mesenchyme (Fig. 1t , dashed arrow).
sox2 transcript is present in the epithelium of the main bronchi (Fig. 2a, black arrow) , except its distal most region (Fig. 2b, bracket) , and its expression appears to be more intense in the trachea region (Fig. 3c, dark arrowhead) . Additionally, sox2 is absent from the secondary bronchi (Fig. 2b, asterisk) . Histological sectioning of hybridized lungs confirms that sox2 is exclusively expressed in the epithelial compartment (Fig. 2d, black arrow) ; as secondary bronchi start to elongate, it is possible to observe sox2 expression in the region where they emerge from the main bronchus, whereas in the distal region it is still absent (Fig. 2d, asterisk) . The expression pattern of secondary bronchi mimics the pattern of the main bronchus.
sox9 mRNA is absent from the epithelial compartment ( Fig. 2e , black arrow) except in the distal tip of the main bronchus (Fig. 2e , bracket) and in the secondary bronchi (Fig. 2f, asterisk) . Moreover, sox9 is present in the mesenchyme of the trachea region (Fig. 3g , dark arrowhead). There seems to be a slight decrease in sox9 expression levels in a stage-dependent manner (from b1 to b3). Slide sectioning revealed that sox9 expression is restricted to the distal tip of the secondary bronchi (Fig. 2f , h, asterisk) while the region where they emerge from the main bronchus lacks sox9. Additionally, sox9 is expressed in the surrounding mesenchyme.
meis1 is expressed in the mesenchyme, namely in the trachea (Fig. 2i , dark arrowhead), in the ventral mesenchyme (Fig. 2k , open arrowhead), and proximal-dorsal region of the lung (Fig. 2i , dashed arrow). In the three stages studied, meis1 is not expressed throughout all the epithelium of the main bronchi (Fig. 2j , k, black arrow) and secondary bronchi (Fig. 2j, asterisk) . Slide sections confirmed the absence of epithelial expression in both the main bronchi and in secondary bronchi (Fig. 2l , black arrow and asterisk, respectively).
meis2 transcript is present all over the mesenchymal compartment ( Fig. 2m-o) and absent from the epithelial compartment ( Fig. 2m -o, black arrow and asterisk). This expression pattern was corroborated in the slide sections that undoubtedly show the lack of expression in the epithelium of the main bronchus and secondary bronchi (Fig. 2p , black arrow and asterisk, respectively), and the abundant expression in the surrounding mesenchyme (Fig. 2p , dashed arrow).
tgfβ2 mRNA is present in the dorsal mesenchyme neighboring the secondary buds (Fig. 2q , dashed arrow) and also in the distal ventral mesenchyme (Fig. 2r, dagger) . In opposition, tgfβ2 has no expression in the epithelium (Fig. 2r , black arrow). Sectioning of selected hybridized lungs illustrated the nonexistence of expression in the main bronchi epithelium (Fig. 2t , black arrow) and in the secondary bronchi ( Fig. 2t , asterisk). Dorsal mesenchyme was identified as mesothelium in the slide sections (Fig. 2t , section sign).
Impact of retinoic acid supplementation in lung branching and gene expression
With the purpose of studying the role of retinoic acid in the embryonic chick lung, b2 lung explants were cultured, in vitro for 48 h, and supplemented with three different doses of RA, selected according to the literature: 0.1, 1, and 10 µM RA. Additionally, a set of b2 lungs was supplemented with DMSO (control group). Lung explants were morphometrically analyzed and probed for selected genes: l-cam, cyp26a1, sox2, sox9, rarβ, meis2, hoxb5, tfgβ2, id2, fgf10, fgfr2, and shh.
Retinoic acid-treated lungs presented an increase in the number of peripheral airway buds when compared with DMSO-treated explants (Fig. 3b , e, h, k). Nonetheless, to provide clear evidence of the increase of lung branching after RA treatment, in situ hybridization for the epithelial marker E-cadherin (L-CAM, in the chick) was performed. In whole mount lungs, l-cam is exclusively expressed in the pulmonary epithelium and the secondary bronchi can be easily recognized (Fig. S3 ). This experimental approach allows an unambiguous visualization of the epithelial tips, demonstrating that there is an increase in the number of secondary buds formed in a dose-dependent manner (Fig. 3c , f, i, l). Morphometric analysis revealed that RA supplementation elicits an increase in branching, indicated by the ratio between the number of secondary buds at D2 and D0, in a dose-dependent manner when compared to DMSO-treated explants (Fig. 4a) . Furthermore, 1 and 10 µM RA doses induced a statistically significant increase in lung branching when compared to DMSOtreated explants. On the other hand, there is no statistically significant difference between the lowest RA dose (0.1 µM) and DMSO, or between the two highest doses (Fig. 4a ). In addition, the D2/D0 ratio of the epithelial and mesenchymal perimeter was determined (Fig. 4b) . RA treatment induced a statistically significant increase in the epithelial perimeter of 1-and 10-µM-treated lungs when compared to control. On the other hand, mesenchymal perimeter did not vary between the different conditions.
To confirm that, after RA supplementation, this signaling pathway was indeed affected, lung explants were probed with cyp26a1, a downstream target and a regulator of RA intracellular levels. Retinoic acid supplementation leads to an increase of cyp26a1 expression levels in a dose-dependent manner (Fig. 5 ). This increase is evident in the explants treated with 1 µM RA when compared with DMSO ( Fig. 5i and c, respectively), and even more clear in the 10-µM-treated explants when compared with control ( Fig. 5l and c, respectively). On the other hand, 0.1-µM-treated explants are similar to control explants. This comparison is possible since all explants were developed for the same amount of time. Moreover, cyp26a1 expression pattern remains unaltered after culture (proximal and dorsal mesenchyme); nonetheless, it extends to all mesenchymal compartments in the highest dose tested (Fig. 5l) .
Taking into consideration that the lowest dose tested (0.1 µM) did not exhibit alterations in cyp26a1 expression levels ( Fig. 5f ) and branching (Fig. 4 ) when compared to control explants, the subsequent studies were performed using only 1 µM and 10 µM RA doses. The expression levels and spatial distribution of several potential downstream targets of retinoic acid signaling (sox2, sox9, rarβ, meis2, hoxb5, tgfβ2, id2, fgf10, fgfr2, and shh) were assessed in RA-and DMSO-treated b2 lung explants by in situ hybridization. From this point onwards, only the images of the in situ hybridization are represented because D0 and D2 images for DMSO, 1, and 10 µM are identical in all cases.
After RA supplementation, sox2 expression levels remain virtually unaltered (Fig. 6a-c) . On the other hand, sox9 expression levels decrease in a dose-dependent manner ( Fig. 6d-f) ; moreover, a progressive loss of the distal expression is also perceived (Fig. 6f) .
RA-treated lungs showed an evident increase in rarβ expression (Fig. 7b, c ) when compared to controls (Fig. 7a) in the tracheal region of the lung. Supplementation studies revealed that only the highest dose tested (10 μM) leads to an increase in meis2 expression levels (Fig. 7f ) when compared to DMSO-treated explants (Fig. 7d) . There seem to be no differences between DMSO and the lowest dose of RA tested. Regarding hoxb5, RAtreated lungs present higher expression levels than control explants (Fig. 7g) . However, the hoxb5 expression is not dose dependent, since 1-and 10-μM-treated explants display similar expression levels (Fig. 7h, i) . In chick lung explants, this gene is expressed mainly in the ventral mesenchyme. RA supplementation caused an increase in tgfβ2 expression levels (Fig. 7k, l ) when compared to control explants (Fig. 7j) , and there seem to be no differences between the two doses tested. In addition, tgfβ2 expression was expanded to the mesenchymal compartment of the lung. As regards id2, after RA supplementation, lung explants displayed an increase in its expression levels (Fig. 7n, o ) when compared to DMSO (Fig. 7m) ; furthermore, in RA-treated lungs, id2 dorsal expression widened to the distal region of the lung, whereas in DMSO-treated lungs it is constrained to the region adjoining the proximal secondary buds (Fig. 7m) . id2 expression pattern in whole mount lungs is described in Fig. S4 . After RA treatment it is possible to observe a slight decrease in fgf10 expression levels (Fig. 8b, c ) when compared to DMSO-treated explants (Fig. 8a) . Likewise, fgfr2 expression levels display a similar trend in RAtreated lungs (Fig. 8d-f ). On its turn, RA supplementation caused a slight increase in shh expression levels (Fig. 8h, i ) when compared to control explants (Fig. 8g ).
Discussion
Retinoic acid plays an essential role during vertebrate embryogenesis, and its distribution and levels must be strictly regulated throughout development. RA signaling is involved in numerous processes such as proliferation, differentiation, and morphogenesis of several organs, namely the lung. Indeed, RA is essential for growth and differentiation of the mammalian lung [12, 46] . Pulmonary development, specifically branching morphogenesis, also depends on the activity of other signaling pathways as, for instance, FGF, WNT or SHH just to name a few [47] . All the signaling pathways involved in this embryonic event regulate and interact with each other, and this finely tuned molecular network leads to the formation of a healthy and fully functional lung. FGF, WNT, and SHH signaling pathways have already been described in the chick embryonic lung, and it has been demonstrated that they interact with each other [4, 5, 7] . Conversely, retinoic acid signaling has not been described hitherto. In this report, we intended to uncover the RA molecular network underlying chick lung branching and to characterize, for the first time, the expression pattern of several RA signaling members in the chick developing lung. For this purpose, we analyzed embryonic chick lungs that display similar anatomic features with mammalian fetal lung; in these early stages, the lateral chick lung branching pattern is similar to one of the mammalian branching subroutines (described by [2] ). In this study, we characterized, by in situ hybridization, the expression pattern of genes involved in RA transport (stra6), biosynthesis (raldh2 and raldh3), degradation (cyp26a1), and signaling regulation (rarα and rarβ). Moreover, the localization of putative RA downstream targets such as sox2, sox9, meis1, meis2, tfgβ2, and id2 (Fig. S4) was also described. Furthermore, the influence of RA on branching was evaluated in vitro, in lung explant cultures supplemented with increasing doses of RA; lung explants were then assessed for gene expression of l-cam, sox2, sox9, cyp26a1, rarβ, meis2, hoxb5, tfgβ2, id2, fgf10, fgfr2, and shh to disclose the molecular network that contributes to RA response. Retinoic acid must go through a series of cellular/enzymatic steps before it reaches the nucleus where it binds to its nuclear receptors. The gateway of RA pathway is STRA6, a transmembrane protein responsible for the main entry of retinol inside the cell, and that influences RA intracellular levels since it can regulate the uptake of vitamin A [18] . Nonetheless, and due to its lipophilic nature, RA can also cross the cellular membrane without the need of a membrane receptor [48] . During chick lung development, stra6 gene is expressed in the periepithelial mesenchyme surrounding the epithelium of the main bronchus until the first secondary bud (Fig. 1a-d) . Furthermore, stra6 mRNA is absent from the entire lung epithelium, and its expression is restricted to proximal mesenchyme, in the three stages studied. This expression pattern is in agreement with what has been described in the mouse lung; in fact, at embryonic day (E) 13.5, stra6 is present in the mesenchyme surrounding the bronchi [49] . It has been reported that homozygous mutations in this gene cause diverse congenital defects, among them lung hypoplasia, congenital diaphragmatic hernia (CDH), and alveolar capillary dysplasia [50, 51] , proving that stra6 plays a key role in lung morphogenesis by mediating retinol influx and thus contributing to the maintenance of RA levels. It is likely that, also in the chick lung, stra6 has a similar function.
raldh2 codes for a key oxidative enzyme of RA pathway and it is mainly expressed in the ventral lung mesenchyme (Fig. 1e, open arrowhead) and in the outermost region of the lung, the mesothelium (Fig. 1h , section sign). This expression pattern remains constant in the three stages studied. In the mouse model, raldh2 is expressed in the lung primordium at E9.5 which suggests that RA signaling is ubiquitously activated at the onset of pulmonary development; actually, raldh2(−/−) knockouts fail to develop lungs [26] . Throughout development, in the early pseudoglandular stage, radlh2 expression becomes more restricted to mesothelial cells and decays towards the distal region of the lung [12] . This feature is also perceived in the embryonic chick lung: there is a decreasing gradient of raldh2 expression at the surface of the avian lung from the proximal-dorsal to the distal-dorsal region. The spatial distribution of this enzyme seems to point to a role of RA in pleura development. In addition, raldh2 expression prevails in areas of low branching activity and presents a complementary pattern to fgf10. Likewise, in the chick lung, this complementary expression pattern is conserved. raldh2 is expressed in the ventral region of the lung, whereas fgf10 is expressed in the dorsal region [4] . In the chick lung, it has been demonstrated that FGF signaling is of utmost importance in the branching process [4] and that the cyst-branch differences are due to regional (ventral-dorsal) alterations of fgf10 levels [52] . It seems likely that retinoic acid signaling might hamper fgf10 expression levels or interfere with extracellular matrix remodeling, namely heparan sulfate proteoglycan levels and, therefore, contribute to the accurate patterning of the lung. In summary, raldh2's presence indicates that RA is being synthesized in chick lung mesenchyme and that, most probably, this signaling pathway is active in this cellular compartment. Nonetheless, there are other factors that might influence the activity of this pathway, namely the existence of degradative enzymes (like CYP26) that contribute to the regulation of RA intracellular levels and the accessibility of retinoic nuclear receptors (RARs).
On the other hand, raldh3 expression was exceptionally faint (data not shown) even after a longer developing process (36 h). In the mammalian lung, raldh3 has been also described as weakly expressed in the lung epithelium of the main bronchi at E12.5-E14.5 [25] . raldh3 knockout mouse displays newborn ocular and nasal defects but does not exhibit lung abnormalities, suggesting that this gene is not relevant for pulmonary morphogenesis [53] . The absence of raldh3 in early stages of chick lung development implies that, perhaps, it may also not be required for lung organogenesis.
Retinoic acid levels must be sharply regulated to maintain adequate signaling activity. Biosynthetic enzymes, such as RALDH2, or degradative enzymes, such as CYP26 (that belong to the cytochrome P450 family), are involved in this regulatory mechanism. cyp26a1 has a very particular expression pattern in the mesenchyme of tracheal region (Fig. 1i, dark arrowhead) . In the mouse fetal lung, at the early pseudoglandular stage (E11.5) cyp26a1 is absent from the tracheal region and confined to the epithelial compartment [12] . Nonetheless, from E14.5 onwards, cyp26a1 expression is detected in both epithelium and mesenchyme, and later (E16.5) it is associated with cartilage rings. Throughout development cyp26a1 progressively expands proximally. In the chick lung, in the three stages studied (that match early mouse pseudoglandular stage), cyp26a1 expression is observed in the lung's proximal region, similar to later stages of mouse fetal lung, and it is perhaps involved in the mechanisms underlying trachea development. Furthermore, it is present in the dorsal mesenchyme surrounding the proximal-most bud (Fig. 1k, dashed arrow) and in the ventral mesenchyme bordering the epithelium; interestingly, raldh2 is expressed in the most peripheral layers of the mesenchyme, in the same regions. This sequential spatial expression of raldh2 and cyp26a1 (from the periphery to the interior of the mesenchymal compartment) most likely regulates the availability of retinoic acid by creating a gradient, due to local degradation of RA by cypa26a1, therefore, affecting the pathway activity and influencing The retinoic acid signaling response is transduced by nuclear retinoic acid receptors (RARα, β, and γ, each having several isoforms) that activate transcription of specific genes by forming a heterodimer with RXR. The vital function of these receptors was disclosed when single and double knockout mice were produced. Mice lacking simply one RAR isoform appeared phenotypically normal [54, 55] , suggesting a functional redundancy mechanism among RAR family. Conversely, double null receptor mutations are lethal in utero or shortly after birth [56] and develop several respiratory tract abnormalities, among them: lung agenesis, lung hypoplasia, and lack of esophageal-tracheal septum [23] . Furthermore, double knockouts with different combinations of RAR subtypes yield different lung phenotypes indicating that RARs (α, β, and γ) have multiple developmental roles in pulmonary morphogenesis [23, 55] . rarα is ubiquitously expressed in the mesenchyme of the entire chick lung in the three stages studied (Fig. 1m-p) . During mammalian embryogenesis, rarα transcripts are universally expressed at all stages and do not vary temporally or spatially [57] ; the same is true in the epithelium of the developing lung [12, 58] . On the other hand, in the chick lung, rarβ exhibits a stage-dependent expression: it is completely absent from stage b1 lungs (Fig. 1q) ; however, in stages b2 and b3 it is detected in the mesenchymal compartment of the most proximal region (Fig. 1r, s) . In the mouse, rarβ2 is expressed as early as E9.5, prior to lung bud formation, and continues in tracheal and lung bud epithelium. By E11-12.5, rarβ2 is found in the epithelium of the proximal bronchi, in the tracheal region (both epithelium and mesenchyme), and it is excluded from the distal part of the lung [12, 57] . In both chick and mouse developing lung, rarβ expression is circumscribed to the proximal region of the lung which may point towards a similar role for rarβ in the morphogenesis of that area. Nevertheless, the cellular compartment is not the same: chick mesenchyme vs. mouse epithelium. In fact, rarα expression pattern presents the same difference. Indeed, all the members of retinoic acid signaling characterized in this study are expressed in the mesenchymal compartment and completely absent the lung epithelium. This feature sustains the hypothesis that, in the chick lung, retinoic acid availability may have a direct effect on mesenchyme morphogenesis while its putative effect in the epithelium must be through the crosstalk with other signaling pathways. In the mouse model, some members of the retinoic acid signaling are expressed in the mesenchyme (stra6, raldh2, and cypa26a1) while others in the epithelium (rarα and rarβ), which is a clear example of epithelial-mesenchyme interactions. It is worth mentioning the lack of rarβ expression in stage b1 lungs. This experiment was repeated several times to confirm this result. Currently we do not have a plausible explanation for this finding; eventually, it might be related to the rarβ isoform that was analyzed since different isoforms may present tissuespecific expression [59] .
Retinoic acid signaling potential targets are expressed in the embryonic chick lung
In the present study, several RA pathway putative downstream targets were also examined in the chick lung, for the first time by in situ hybridization. These genes were selected based on the current knowledge of RA signaling in processes such as limb development (meis1 and meis2) [60] and also on the available data from mammalian lung development (tfgβ2) [61] . Additionally, sox2 and sox9 (and id2) were also characterized since they are differentially expressed in the mammalian lung establishing the proximal vs. distal fate of the respiratory tree, respectively [62, 63] , and because RA signaling regulates lung patterning [12] .
sox2 and sox9 belong to the SRY-related HMG-box family of transcription factors that play numerous functions during embryonic development, among them, regulation of cell specification and differentiation (reviewed by [64] ). In the pulmonary context, sox2 and sox9 are particularly important for the proliferation and differentiation of upper and lower branching epithelium, respectively (reviewed by [65] ). In the chick lung, sox2 is exclusively expressed in the epithelium of the main bronchus, except its distal tip (Fig. 2a-d) . This expression pattern is very similar to the mammalian lung [62] and it is in agreement with a previous study in the avian lung [66] . sox2 is expressed in the foregut endoderm and it has been implicated in trachea and esophagus morphogenesis [67, 68] . As lung development proceeds, during branching morphogenesis, sox2 is restricted to pulmonary epithelium but it is not detectable at the tips of the emerging secondary bronchi budding out from the primary bronchus. In fact, it has been shown that loss of sox2 at branching sites is required for branching morphogenesis to occur; additionally, sox2 is also necessary for the timely differentiation and proliferation of the proximal airway epithelium [62, 69] . It is possible that, also in the chick lung, sox2 plays a similar function considering that its expression is equivalent to the mammalian lung. sox9 is expressed in the epithelial tip of the main bronchi and secondary bronchi, and in the mesenchyme surrounding the proximal region of the lung (Fig. 2e-h ). This expression pattern matches its mammalian counterpart [70] . In the mouse lung, the absence of proximal mesenchymal sox9 expression impairs cartilage development [71, 72] and proper tracheal epithelium differentiation [73] . At the epithelial level, sox9 (and id2)-expressing cells delimit the distal branching epithelium and originate distal pulmonary cell lineages [63] . Recently, it has been demonstrated that SOX9 is crucial for the regulation of branching morphogenesis by controlling not only proliferation and differentiation but also extracellular matrix composition [63] . Taking into account that sox9 spatial distribution in the avian lung is comparable to the mouse lung, it is reasonable to assume that it might have a similar role. It is worth mentioning that id2 (inhibitor of differentiation 2) expression is not an absolute match to its mammalian counterpart (Fig. S4) . In fact, in the mouse lung, id2 is exclusively transcribed in the epithelial tip cells of the developing lung. Additionally, it has been demonstrated that Sox9+/Id2+ cells are initially capable of generating both airway and alveolar epithelium until E13.5; after this time point, these progenitors can only generate alveolar cells [74] . In the chick lung, id2 is widely expressed in the mesenchyme although it is also present in the epithelial tips. This spatial distribution may point toward other roles for id2 in chick lung development.
Homeobox genes, meis1 and meis2, are downstream targets of retinoic acid signaling and have been directly implicated in proximal-distal limb patterning [60] . Likewise, RA is an upstream activator of meis2 during telencephalon development, namely in the dorsoventral patterning of neural progenitor cells [75] . However, the presence of these genes during lung development has not been described up to now. meis1 and meis2 display a similar expression pattern. They are ubiquitously and exclusively expressed in the mesenchymal compartment and absent from lung epithelium (Fig. 2i-p) . In the chick embryo, meis genes are limited to the proximal region of the limb [60, 76] and confined to the intermediate subdivision of the telencephalon [75] ; in both cases, they were associated with axis patterning. Considering the widespread expression of meis in the chick lung, contrasting with the aforementioned events, it is probable that meis genes may perform another type of function in lung morphogenesis.
The transforming growth factor-β (TGFβ) superfamily of secreted cytokines has three subtypes. In this report, the expression pattern of tgfβ2, which has been associated with mammalian lung development [60] , was investigated. In the chick developing lung, tgfβ2 mRNA is present in the mesenchyme surrounding the secondary bronchi (Fig. 2q, dashed arrow) , in the mesothelium layer (Fig. 2t,  section sign ) and, to a lesser extent, in the distal ventral mesenchyme (Fig. 2r, dagger) . This expression pattern is quite different from its mammalian counterpart that is mainly expressed in the distal epithelium and absent from the proximal region of the lung [77, 78] . Remarkably, tgfβ2 expression pattern in the chick lung resembles tgfβ3 expression in the mouse lung, at E11.5. tgfβ3 is detected in the proximal mesenchyme and, in addition, the pulmonary mesothelium [78] . A previous study had already reported the presence of tgfβ2 in the mesenchyme and pleura of stage 27 chick lungs and correlated this expression with tgfβ1 spatial localization [39] . In the chick developing lung, tgfβ2 expression is different but still comparable to a different mammalian isoform.
To conclude, all the genes belonging to the RA machinery characterized in this report share a common characteristic: they are all solely expressed in the mesenchymal compartment, although differently distributed along the proximal-distal and dorsoventral axis of the developing chick lung. This feature seems to be species specific but, nonetheless, it is reasonable to believe that retinoic acid signaling most probably influences proliferation and differentiation and hence contributes to chick lung branching morphogenesis.
Retinoic acid signaling and chick lung branching and patterning
Retinoic acid versatility extends from embryonic development to the adult stage [20, 79] ; however, regardless of the context, RA intracellular levels must be finely regulated to assure the appropriate signaling activity. In the mammalian lung, RA is of paramount importance during primary bud formation, branching morphogenesis, and alveologenesis (reviewed in [80] ). Once we have shown that all the retinoic signaling machinery is present in the chick lung, we asked what would be the impact of RA supplementation in chick lung branching, in vitro. For this purpose, b2 chick lung explants were supplemented with three different doses of RA selected according to the literature [81] ; additionally, lung explants were also treated with DMSO as it is a RA solvent.
Morphometric analysis, measured as the D2/D0 ratio of the number of peripheral buds, revealed that RA supplementation increases chick lung branching in a dosedependent manner (1 and 10 µM) when compared to DMSO (Fig. 4a) . Furthermore, 0.1 µM RA-treated explants were comparable to controls. Representative explants of the four experimental conditions were probed with l-cam (an epithelial marker) to reinforce the data of the morphometric analysis. With this approach, it is visually evident that the number of secondary buds formed augments in a dose-dependent manner (Fig. 3c, f, i, l) . Additionally, RA treatment triggers an increase in the D2/D0 ratio of the epithelial perimeter corroborating the data regarding the number of secondary buds formed in 1-and 10-µM-treated lungs; nonetheless, the mesenchymal perimeter remains unaltered (Fig. 4b) . Similar results were obtained following fetal rat lung explants' treatment with exogenous 1 µM RA, for 96 h; an increase in the number of peripheral buds, epithelium perimeter, and total area of the lung was reported [82] . A previous study, using fetal mouse lung, described that 1 µM RA treatment for 48 h promotes branching; however, the new distal buds formed look like proximal branches [83] . Actually, several reports have revealed that RA treatment, in vitro, decreases the average terminal bud number and that the new terminal buds formed present a "proximal-like" aspect [58, 81] . It has been demonstrated that the expression levels and, importantly, the spatial distribution of distal markers of differentiation, such as surfactant proteins, are impaired [64, 67] . Moreover, it has been shown that the expression of genes involved in organ patterning, as for instance hox genes (among many others), is compromised when lungs are supplemented with RA, which may explain the impairment in the proximal-distal organization of the lung [84, 85] . Overall, these experiments indicate a clear role for retinoic acid signaling in the proximal-distal patterning of the early mammalian lung, most likely by interfering with the expression of genes involved in cell fate identity.
To confirm that the observed results were indeed a result of the activation of RA signaling, chick lung explants were probed with cyp26a1, a downstream target of RA signaling and part of a feedback mechanism controlling RA availability [12] . This enzyme can oxidize RA and, consequently, regulate its intracellular levels and limit RA signaling activity (since high levels may have a detrimental effect). RA supplementation increased cyp26a1 expression level in a dose-dependent manner (Fig. 5) indicating an increase in signaling activity. This comparison is possible since all explants were developed for the same amount of time. It seems like DMSO and 0.1-µM-treated explants (Fig. 5c and f, respectively) do not express cyp26a1. This is probably due to the fact that the developing reaction had to be stopped to prevent further signal in 10-µM-treated explants (Fig. 5l) , and it is not an effect of the in vitro culture system or a real lack of cyp26a1 expression. In 1-and 10-µM-treated explants, cyp26a1 is expressed in the proximal and dorsal mesenchyme, similar to whole mount lungs. Nonetheless, the highest RA dose triggers an ectopic expression of this gene in the mesenchymal compartment, surrounding branching and non-branching regions. With this experiment, we can assure that, in the chick lung, cyp26a1 is also a target of retinoic acid signaling pathway since its expression is upregulated with RA supplementation. Hence, it is reasonable to assume that the observed increase in branching is a result of RA signaling activation. Moreover, the loss of cyp26a1 proximal-distal spatial distribution probably will interfere with lung patterning.
In the embryonic chick lung, retinoic acid supplementation causes an evident augment in branching (Figs. 3, 4) . To clarify if this increase was accompanied by an alteration in the proximal-distal patterning of the chick lung, as it occurs in the mammalian lung, the expression levels of early molecular markers of proximal (sox2) and distal (sox9) airway progenitors were evaluated (Fig. 6) . Retinoic acid had no impact on sox2 expression levels which may well indicate that proximal epithelial fate and proximal structures, such as the conducting airways, would develop normally. Indeed, sox2 overexpression in the lung epithelium impairs epithelial differentiation and prematurely commits cells to a specific differentiation program [62] , while sox2 deletion diminishes the mature secretory and ciliated lineages in the respiratory tree [69] . Conversely, sox9 spatial distribution and expression levels were affected by RA supplementation. It has been demonstrated that epithelial-specific loss of sox9 triggers the formation of cyst-like structures at the distal epithelial branch tips with concomitant defects in the differentiation of distal progenitor cells [63, 86] , whereas sox9 overexpression blocks the differentiation of distal epithelial progenitors [63] . In the particular case of the chick lung, the decrease in sox9 expression levels may lead to a decrease in distal epithelial multipotent progenitors and induce a proximal differentiation program. Simultaneously, sox9 spatial distribution was altered by RA and it was progressively excluded from the distal regions of the lung but maintained in the proximal mesenchyme; this change in the expression pattern may, likewise, contribute to the disproportion of the proximal vs. distal cell phenotype. Taken together, these results seem to point to an alteration in the fate of distal cells, while proximal cells will probably not be affected, even though new distal branches do not exhibit a proximal appearance. Overall, these results imply that retinoic acid may be a regulator of the proximal-distal patterning of the embryonic chick lung, as it occurs in the mammalian lung and that it is involved in the epithelial-mesenchymal interactions that guide avian pulmonary morphogenesis.
Retinoic acid signaling molecular network
Retinoic acid signaling pathway conveys its cellular response by up/down regulating the transcription of several target genes, which regulate biological processes such as proliferation, differentiation, and patterning, through the action of retinoic acid nuclear receptors. Taking this into consideration, we sought to unveil the molecular network that might be orchestrating retinoic acid action during chick lung branching, in vitro. In this sense, explants treated with 1 and 10 µM were evaluated for the expression levels of selected genes. Since 0.1 µM dose did not display differences in both branching and cypa26a1 expression levels, we opted to exclude it from the subsequent studies.
From the RA signaling components characterized in the previous sections, we decided to analyze rarβ expression levels since it had already been shown that RARβ protein levels [82] and rarβ expression levels [58] increased after RA supplementation. Data regarding rarα were not so evident and, therefore, we selected only one nuclear receptor. raldh2 was not assessed for two main reasons: on the one hand, the oxidative reaction catalyzed by RALDH2 is surpassed in our in vitro experimental setup because we supplemented directly with RA, the end product of this reaction; furthermore, the reaction catalyzed by this enzyme is irreversible implicating that the interconversion of RA to retinal is not feasible, which means that RA levels must be regulated by the action of CYP26 enzymes (as it is observed in Fig. 5 ). STRA6 transporter facilitates the entrance of retinol into the embryonic cells when attached to a retinol-binding protein (RBP4); since the in vitro experimental setup used lacks both retinol and RBP4, the predominant method for RA entrance is membrane diffusion. For this reason, stra6 was not evaluated as a target.
rarβ is one of the transducers of RA cellular response since it behaves as a final decision maker by interacting with the promoter region of target genes. RA supplementation increased rarβ expression levels ( Fig. 7a-c ) and its spatial distribution was similar to the proximal/tracheal localization observed in whole mount lungs (Fig. 1r, s) . It has been demonstrated, in the rat model, that explants treated with 1 µM RA present a decrease in RARα and RARγ and an increase in RARβ protein levels revealing a direct regulation of RAR by RA [82] . A previous study also demonstrated the interplay between RA and its own receptor [58] . Mollard and coworkers showed that mouse fetal lung explants supplemented with 1 µM RA display an obvious increase in rarβ expression levels; nonetheless, the spatial distribution is quite altered [58] . rarβ is ectopically expressed in the distal buds as a result of RA signaling activation, whereas RA signaling inhibition leads to a decrease in rarβ expression levels in the proximal region. These data prompt the authors to propose that RARβ favors morphogenetic stabilization over de novo budding during formation of the pulmonary tree since they observed a proximalization of the distal region of the lung following RA treatment. Moreover, it has been proved that rarβ2, together with rarα, is crucial for the formation of the mouse tracheal-esophageal septum, among other events. In double αβ2 mutants, the separation between the esophagus and the trachea fails to occur [23] . Our results suggest that, as it occurs in the mammalian lung, rarβ is a target of RA signaling in the chick lung and imply that, at least in the proximal region, it might be implicated in the cellular response conveyed by RA and probably also implicated tracheal morphogenesis. Since we did not observe an expansion of the rarβ expression domain after RA supplementation, it is probably not directly related to the proximal-distal cell fate decision.
Retinoic acid signaling has been associated with transcriptional regulation of genes crucial for pattern formation and cell fate decision, such is the case of homeobox genes that code for a large family of transcription factors. There are 16 major classes of homeobox genes, among them hox and meis (reviewed in [87] ). hox temporal-spatial distribution is crucial for providing the correct vertebra identity [88] . In the chick lung, it has been disclosed that hoxb5 to hoxb9 expression pattern correlates with the morphological subdivisions of the bronchial tree and the air sacs [89] . Regarding meis genes, they have been identified as determinants of proximal limb compartments and telencephalon development [75, 76] . Interfering with retinoic acid signaling alters patterning and it has been described that it alters hox [90] and meis genes [60, 75] . In this report, we aimed to elucidate if, in the developing chick lung, hox and meis expressions were also retinoic acid dependent. Since the expression patterns of meis1 and meis2 described in this report are similar, we choose to study only meis2 gene in this context. RA supplementation revealed that only the highest dose tested (10 µM) results in an increase in meis2 expression levels, especially in the ventral mesenchyme (Fig. 7f) , but its distribution is comparable to whole lungs ( Fig. 2m-o) . This is, to the best of our knowledge, the first evidence in the literature of this association during lung development. As hoxb5 is concerned, its expression is augmented in RA-treated explants although there are no differences between the two doses tested (Fig. 7g-i) . The spatial distribution of this gene is in agreement with the expression pattern described at E5 by others [89] ; hoxb5 is highly expressed in the ventral mesenchyme and, to a much lesser extent, in the dorsal mesenchyme. In the mouse lung, it has been shown that HOXB5 levels increase in the mesenchyme adjacent to the elongated airways that emerge in terminal region of the lung, after RA treatment [85] ; based on these findings, Volpe and coworkers suggest that this imbalance might be the cause of loss of distal phenotype in RA-treated lungs, probably through the modulation of extracellular matrix components [85, 91] . In the embryonic chick lung, it seems clear that hoxb5 is expressed in response to RA; nonetheless, and as it occurs with meis2, it maintains its spatial distribution.
Retinoic acid is part of a complex regulatory mechanism that, in the end, leads to primary bud formation. It has been shown that TGFβ inhibition by RA in the developing foregut is required for fgf10 expression and, consequently, primary bud induction [27, 92] . Furthermore, in the mammalian lung, TGFβ signaling also plays a key role in branching morphogenesis. In general, the levels of TGFβ ligands and their cognate receptors must be finely regulated throughout development to assure that signaling occurs at the right time and place. In fact, TGFβ type II receptor contributes to a distinct TGFβ response in the epithelial and mesenchymal compartments [93] . TGFβ null mutant's display, among other features, abnormal fetal lung development [94] ; additionally, in vitro studies have shown that addition of TGFβ1, β2, or β3 decreases branching [78] . TGFβ signaling is also important for chick lung development. Explants treated with TGFβ1 exhibit a decrease in branching in a dose-dependent manner; on the other hand, blocking TGFβ receptor type I enhances branching, even though it decreases lung size [10] . Taking all this into consideration we asked if retinoic acid modulates tgfβ2 expression during branching, as it occurs in the early foregut. RA supplementation causes an increase in tgfβ2 expression levels, which is not dose dependent, and an expansion of tgfβ2 expression domain (Fig. 7j-l) , similar to cyp26a1 (Fig. 5) . The widespread expression of both genes after retinoic acid treatment suggests the existence of a regulatory mechanism between RA and TGFβ signaling pathways responsible for maintaining signaling at the right time and place. TGFβ signaling cellular response depends on the existence of receptors that are present in the neighboring cells, in the mesenchymal and/or epithelial compartment. It has been shown that TGFβ signaling is able to alter N-myc epithelial expression [95] , cyclin A [96] , and mesenchymal α-smooth muscle actin [78] .
The Id (inhibitor of DNA binding/differentiation) proteins are a subfamily of the helix-loop-helix transcription factors that play key roles in the regulation of cell cycle progression and cell differentiation [97] . Id factors may be regulated by TGFβ signaling and contribute to coordinate proliferation and differentiation in a cell-specific manner. In RA-treated lungs, id2 mesenchymal dorsal expression widens in the distal region of the lung (Fig. 7m-o ) similar to what is observed with tgfβ2 spatial distribution, in the same culture conditions (Fig. 7j-l) . Indeed, it has been shown that TGFβ2 upregulates Id2 leading to cell death inhibition and ectopic digit formation in the chick limb [44] . Taking this into consideration, it is likely that RA stimulation in the chick lung leads to an increase in tgfβ levels/signaling that consequently increases id2 levels that may alter the proliferation/differentiation state of the distal cells, thus contributing to an increase in branching.
Lung branching morphogenesis is a particularly complex developmental event that relies in the interaction of distinct molecular players, namely FGF10 and its cognate receptor FGFR2 [98, 99] and SHH (reviewed in [100] ). Additionally, in the mouse lung, it has been demonstrated that fgf10 expression is downregulated and limited to the most peripheral areas of the lung after the exogenous RA activation; moreover, in the same experimental conditions, SHH pathway is upregulated [12, 29] . FGF and SHH signaling are also crucial for avian lung development [4, 5, 8] . Taking this into consideration, we questioned if the expressions of these well-known regulators of pulmonary development were RA dependent in the chick lung. RA supplementation triggered only a mild decrease in fgf10 and fgfr2 expression levels (Fig. 8a-f ) and a slight increase in shh levels of expression in the highest dose tested (Fig. 8g-i) . To a certain degree, it is in agreement with what happens in the mammalian lung. It means that, despite the fact that RA machinery is confined to the mesenchymal compartment, it is able to influence the expression of epithelial genes such as fgfr2 and shh, and also sox9.
In general, there seems to be regional specificity regarding RA signaling in the chick lung, which defines the proximal and distal areas of the avian lung. Nonetheless, when compared to the mammalian lung, RA treatment elicited differences regarding specific genes which could be explained by the specifics of the avian lung.
Final remarks
Retinoic acid is crucial in different stages of mammalian lung development, and it has been associated with the proximal-distal patterning of the early lung. To date, this signaling pathway had not been characterized in the avian lung. The major findings of this report are summarized in Fig. 9 . All the RA signaling members described in this study are exclusively expressed in the mesenchyme, whereas in the mammalian lung, there is a combined expression of mesenchymal and epithelial compartments. From these data, we can speculate that, in the chick lung, RA directly modulates the expression of mesenchymal target genes, via RARs, that will contribute to accurate lung development and, accordingly, to the pathway activity. On the other hand, its effect on the epithelial compartment (sox9) is most likely dependent on the interaction with other molecular players known to be involved in epithelial-mesenchymal interactions. Retinoic acid stimulated lung branching when added exogenously and, although apparently it seems not to interfere with the proximal-distal pattern of the new branches Fig. 9 Retinoic acid signaling pathway in the embryonic chick lung. Retinol enters the cell mainly through STRA6 transmembrane protein in the proximal region of the lung (single asterisk) and, eventually, by diffusion in the distal region (double asterisks). Cytoplasmic retinol is converted into retinal, which is then oxidized into retinoic acid by RALDH2 enzyme. The intracellular retinoic acid may have two different fates, it can be metabolized by CYP26A1 or transported to the nucleus. In the nucleus, RA interacts with RARs, namely rarα and rarβ, and RXR; these heterodimers interact with RAREs in the promoter region of RA target genes, thus modulating their transcription. In this report we show two groups of RA target genes: (1) RA machinery genes: cyp26a1 and rarβ; (2) RA interaction with other signaling pathways: sox9, meis2, hoxb5, tgfβ2, id2, fgf10, fgfr2, and shh formed, at the molecular level sox9 expression is impaired which points toward a defective pulmonary patterning. Increased cyp26a1 expression levels revealed that RAinduced signaling is active in these conditions. Likewise, altered levels of hoxb5, meis2, tgfβ2, id2, and fgf10, fgfr2, and shh (only faintly) uncover intricate molecular interactions between different signaling pathways that, eventually, control lung branching morphogenesis. RA seems to regulate patterning and branching in the chick lung by maintaining signaling at the right time and place. This report contributes to the description of the molecular network underlying chick lung development and highlights the species-specific features of the avian lung.
